 Connection
Evgenia Dobrinskikh to Obesity
This is a "connection" page, showing publications Evgenia Dobrinskikh has written about Obesity.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.121 |
|
|
|
-
Wang XX, Wang D, Luo Y, Myakala K, Dobrinskikh E, Rosenberg AZ, Levi J, Kopp JB, Field A, Hill A, Lucia S, Qiu L, Jiang T, Peng Y, Orlicky D, Garcia G, Herman-Edelstein M, D'Agati V, Henriksen K, Adorini L, Pruzanski M, Xie C, Krausz KW, Gonzalez FJ, Ranjit S, Dvornikov A, Gratton E, Levi M. FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity. J Am Soc Nephrol. 2018 01; 29(1):118-137.
Score: 0.056
-
Wang XX, Edelstein MH, Gafter U, Qiu L, Luo Y, Dobrinskikh E, Lucia S, Adorini L, D'Agati VD, Levi J, Rosenberg A, Kopp JB, Gius DR, Saleem MA, Levi M. G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes. J Am Soc Nephrol. 2016 05; 27(5):1362-78.
Score: 0.049
-
Vestal M, Li L, Dobrinskikh E, Shi Y, Wang B, Shi X, Li S, Vestal C, Parker K. Rapid MALDI-TOF molecular imaging: Instrument enhancements and their practical consequences. J Mass Spectrom. 2020 Aug; 55(8):e4423.
Score: 0.016
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|